Is Revolution Medicines a Good Stock to Own?
Though it’s still quite early in the year, pharmaceutical startup…
Sell
39
CLDT Quote, Financials, Valuation and Earnings
Last price:
$6.92
Seasonality move
:
-5.68%
Day range:
$6.88 - $7.03
52-week range:
$5.83 - $8.98
Dividend yield:
5.21%
P/E ratio:
622.52x
P/S ratio:
1.13x
P/B ratio:
0.45x
Volume:
190.1K
Avg. volume:
271.6K
1-year change:
-21.39%
Market cap:
$335.2M
Revenue:
$317.2M
EPS (TTM):
$0.01
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $144.9M | $204M | $294.9M | $311.1M | $317.2M | |
| Revenue Growth (YoY) | -55.86% | 40.75% | 44.55% | 5.51% | 1.96% | |
| Cost of Revenues | $159.7M | $178.6M | $216.6M | $229.5M | $237.9M | |
| Gross Profit | -$14.8M | $25.3M | $78.3M | $81.6M | $79.3M | |
| Gross Profit Margin | -10.22% | 12.42% | 26.55% | 26.22% | 25% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | -$6M | $16.9M | $2.1M | -$4.8M | $1.4M | |
| Operating Expenses | $32.7M | $36.9M | $44.1M | $48.7M | $47.5M | |
| Operating Income | -$47.5M | -$11.6M | $34.2M | $32.9M | $31.8M | |
| Net Interest Expenses | $26.6M | $24.5M | $27.2M | $27.1M | $30.9M | |
| EBT. Incl. Unusual Items | -$77M | -$18.8M | $9.9M | $2.5M | $4M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | -- | |
| Net Income to Company | -$77M | -$18.8M | $9.9M | $2.5M | $4M | |
| Minority Interest in Earnings | -$997K | -$435K | $66K | -$156K | -$131K | |
| Net Income to Common Excl Extra Items | -$77.1M | -$18.8M | $9.8M | $2.4M | $3.9M | |
| Basic EPS (Cont. Ops) | -$1.62 | -$0.46 | $0.04 | -$0.11 | -$0.08 | |
| Diluted EPS (Cont. Ops) | -$1.62 | -$0.46 | $0.04 | -$0.11 | -$0.08 | |
| Weighted Average Basic Share | $47M | $48.3M | $48.8M | $48.8M | $48.9M | |
| Weighted Average Diluted Share | $47M | $48.3M | $49.1M | $48.8M | $48.9M | |
| EBITDA | $6.4M | $42.7M | $93.5M | $91.1M | $92.5M | |
| EBIT | -$47.5M | -$11.6M | $34.2M | $32.9M | $31.8M | |
| Revenue (Reported) | $144.9M | $204M | $294.9M | $311.1M | $317.2M | |
| Operating Income (Reported) | -$47.5M | -$11.6M | $34.2M | $32.9M | $31.8M | |
| Operating Income (Adjusted) | -$47.5M | -$11.6M | $34.2M | $32.9M | $31.8M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $64.3M | $87.9M | $86.7M | $87.2M | $78.4M | |
| Revenue Growth (YoY) | 83.86% | 36.69% | -1.3% | 0.5% | -10.06% | |
| Cost of Revenues | $49.4M | $57.4M | $61.1M | $62.8M | $57.7M | |
| Gross Profit | $14.9M | $30.4M | $25.6M | $24.4M | $20.7M | |
| Gross Profit Margin | 23.22% | 34.64% | 29.51% | 27.96% | 26.42% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | -$7K | $109K | -$4K | -$14K | -- | |
| Operating Expenses | $10.5M | $11.8M | $11.7M | $11.9M | $10.8M | |
| Operating Income | $4.4M | $18.7M | $13.9M | $12.5M | $9.9M | |
| Net Interest Expenses | $3.5M | $6.8M | $6.8M | $8.3M | $6.2M | |
| EBT. Incl. Unusual Items | -$1.4M | $12.4M | $7.5M | $4.3M | $3.6M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | -- | |
| Net Income to Company | -$1.4M | $12.4M | $7.5M | $4.3M | $3.6M | |
| Minority Interest in Earnings | -$64K | $248K | $170K | $88K | $56K | |
| Net Income to Common Excl Extra Items | -$1.4M | $12.4M | $7.5M | $4.3M | $3.5M | |
| Basic EPS (Cont. Ops) | -$0.07 | $0.21 | $0.11 | $0.05 | $0.03 | |
| Diluted EPS (Cont. Ops) | -$0.07 | $0.21 | $0.11 | $0.05 | $0.03 | |
| Weighted Average Basic Share | $48.8M | $48.8M | $48.9M | $48.9M | $48.9M | |
| Weighted Average Diluted Share | $48.8M | $49.1M | $49M | $49.1M | $49.6M | |
| EBITDA | $18.1M | $33.3M | $28.6M | $27.8M | $24.6M | |
| EBIT | $4.4M | $18.7M | $13.9M | $12.5M | $9.9M | |
| Revenue (Reported) | $64.3M | $87.9M | $86.7M | $87.2M | $78.4M | |
| Operating Income (Reported) | $4.4M | $18.7M | $13.9M | $12.5M | $9.9M | |
| Operating Income (Adjusted) | $4.4M | $18.7M | $13.9M | $12.5M | $9.9M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $176.2M | $206.1M | $309.2M | $314.4M | $302.4M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $167.1M | $210.4M | $227M | $235.7M | $230.4M | |
| Gross Profit | $9.1M | -$4.3M | $82.1M | $78.7M | $72M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | $40.8M | -$3.5M | -$475K | -$4.5M | -- | |
| Operating Expenses | $36.7M | $42M | $46.2M | $49.5M | $45.4M | |
| Operating Income | -$27.6M | -$46.3M | $35.9M | $29.2M | $26.6M | |
| Net Interest Expenses | $20.1M | $26.2M | $26.6M | $30.7M | $27.1M | |
| EBT. Incl. Unusual Items | -$10.8M | $553K | $9.7M | -$3.4M | $8.8M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | -- | |
| Net Income to Company | -$10.8M | $554K | $9.7M | -$3.4M | $8.8M | |
| Minority Interest in Earnings | -$226K | -$91K | $99K | -$339K | $16K | |
| Net Income to Common Excl Extra Items | -$10.8M | $553K | $9.6M | -$3.6M | $8.6M | |
| Basic EPS (Cont. Ops) | -$0.26 | -$0.15 | $0.03 | -$0.23 | $0.01 | |
| Diluted EPS (Cont. Ops) | -$0.26 | -$0.15 | $0.03 | -$0.23 | $0.01 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | $26.2M | $12.5M | $93.9M | $89.3M | $87M | |
| EBIT | -$27.6M | -$46.3M | $35.9M | $29.2M | $26.6M | |
| Revenue (Reported) | $176.2M | $206.1M | $309.2M | $314.4M | $302.4M | |
| Operating Income (Reported) | -$27.6M | -$46.3M | $35.9M | $29.2M | $26.6M | |
| Operating Income (Adjusted) | -$27.6M | -$46.3M | $35.9M | $29.2M | $26.6M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $146.7M | $148.8M | $238.8M | $242.1M | $227.3M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $130.5M | $162.2M | $172.7M | $178.8M | $171.3M | |
| Gross Profit | $16.2M | -$13.4M | $66.2M | $63.3M | $56.1M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | $22.6M | $2.1M | -$476K | -$171K | $7.5M | |
| Operating Expenses | $27.6M | $32.7M | $34.8M | $35.6M | $33.5M | |
| Operating Income | -$11.4M | -$46.2M | $31.3M | $27.7M | $22.6M | |
| Net Interest Expenses | $13.7M | $20.4M | $19.7M | $23.3M | $19.5M | |
| EBT. Incl. Unusual Items | -$7.4M | $12M | $11.8M | $5.9M | $10.6M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | -- | |
| Net Income to Company | -$7.4M | $12M | $11.8M | $5.9M | $10.6M | |
| Minority Interest in Earnings | -$178K | $166K | $198K | $15K | $162K | |
| Net Income to Common Excl Extra Items | -$7.4M | $12M | $11.7M | $5.8M | $10.5M | |
| Basic EPS (Cont. Ops) | -$0.19 | $0.12 | $0.11 | -$0.00 | $0.09 | |
| Diluted EPS (Cont. Ops) | -$0.19 | $0.12 | $0.11 | -$0.00 | $0.09 | |
| Weighted Average Basic Share | $144.6M | $146.4M | $146.5M | $146.7M | $146.9M | |
| Weighted Average Diluted Share | $144.8M | $146.9M | $146.8M | $147M | $148.1M | |
| EBITDA | $28.9M | -$1.2M | $75M | $73.2M | $67.7M | |
| EBIT | -$11.4M | -$46.2M | $31.3M | $27.7M | $22.6M | |
| Revenue (Reported) | $146.7M | $148.8M | $238.8M | $242.1M | $227.3M | |
| Operating Income (Reported) | -$11.4M | -$46.2M | $31.3M | $27.7M | $22.6M | |
| Operating Income (Adjusted) | -$11.4M | -$46.2M | $31.3M | $27.7M | $22.6M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $31.5M | $29.9M | $45.2M | $85.7M | $29.8M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $1.7M | $3M | $5.2M | $4.4M | $2.9M | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $33.1M | $32.9M | $50.3M | $90.1M | $32.8M | |
| Property Plant And Equipment | -- | -- | -- | -- | -- | |
| Long-Term Investments | -- | $61K | $800K | -- | -- | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | $2.3M | $2.8M | $3.4M | $3.8M | $2.8M | |
| Total Assets | $1.4B | $1.4B | $1.3B | $1.3B | $1.3B | |
| Accounts Payable | $25.4M | $27.7M | $28.5M | $29.3M | $29.6M | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $67.2M | $38.8M | $151.7M | $59.3M | $191.2M | |
| Long-Term Debt | $610.6M | $557.7M | $374M | $480.3M | $271.5M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $677.8M | $596.5M | $525.7M | $539.6M | $462.7M | |
| Common Stock | $470K | $487K | $488K | $488K | $489K | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | $677.8M | $797.5M | $794.8M | $776M | $758.2M | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $14.7M | $16.7M | $23.1M | $28.3M | $33.8M | |
| Total Equity | $692.5M | $814.2M | $818M | $804.4M | $792M | |
| Total Liabilities and Equity | $1.4B | $1.4B | $1.3B | $1.3B | $1.3B | |
| Cash and Short Terms | $31.5M | $29.9M | $45.2M | $85.7M | $29.8M | |
| Total Debt | $632M | $567M | $492M | $504.9M | $427.5M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $29.6M | $34.2M | $90M | $28.8M | $21.4M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $3.2M | $15.2M | $5.2M | $4.4M | -- | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $32.8M | $49.4M | $95.2M | $33.2M | $25.3M | |
| Property Plant And Equipment | -- | -- | -- | -- | -- | |
| Long-Term Investments | $41K | $700K | -- | -- | -- | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | $5.1M | $6.4M | $6.2M | $6.2M | -- | |
| Total Assets | $1.4B | $1.4B | $1.4B | $1.3B | $1.2B | |
| Accounts Payable | $30.8M | $34.3M | $35.8M | $34.6M | -- | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $35.4M | $38.5M | $43M | $54.4M | $38M | |
| Long-Term Debt | $564.1M | $491.8M | $505.1M | $442.4M | $379.3M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $599.4M | $530.3M | $548.1M | $496.9M | $397.1M | |
| Common Stock | $487K | $488K | $488K | $489K | $487K | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $15.9M | $22.1M | $27.4M | $32.8M | $36M | |
| Total Equity | $826.5M | $824.4M | $817.8M | $798.1M | $785.5M | |
| Total Liabilities and Equity | $1.4B | $1.4B | $1.4B | $1.3B | $1.2B | |
| Cash and Short Terms | $29.6M | $34.2M | $90M | $28.8M | $21.4M | |
| Total Debt | $566.5M | $494.4M | $507M | $456.7M | $379.3M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$77M | -$18.8M | $9.9M | $2.5M | $4M | |
| Depreciation & Amoritzation | $53.9M | $54.2M | $59.4M | $58.3M | $60.7M | |
| Stock-Based Compensation | $4.6M | $4.8M | $5.6M | $6.1M | $6.4M | |
| Change in Accounts Receivable | $2.9M | -$1.3M | -$2.2M | $803K | $1.3M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$20M | $28.8M | $71.5M | $76.4M | $73.8M | |
| Capital Expenditures | $14.5M | $9.5M | $15.7M | $28.1M | $31.3M | |
| Cash Acquisitions | -- | $71.3M | $31M | -- | $43.7M | |
| Cash From Investing | $26.8M | -$101.9M | $30M | -$28.1M | -$29.2M | |
| Dividends Paid (Ex Special Dividend) | $16.2M | $2.6M | $8.1M | $22.2M | $22.3M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $99.3M | $111.7M | $44.3M | $172.9M | $260.3M | |
| Long-Term Debt Repaid | -$76.4M | -$176.5M | -$119M | -$157.1M | -$337.2M | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -$2.4M | -$5.6M | -$3.5M | -$1.5M | -$1.3M | |
| Cash From Financing | $4.4M | $71.6M | -$86.2M | -$7.7M | -$100.6M | |
| Beginning Cash (CF) | $31.5M | $29.9M | $45.2M | $85.7M | $29.8M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $11.3M | -$1.6M | $15.3M | $40.6M | -$55.9M | |
| Ending Cash (CF) | $42.7M | $28.3M | $60.4M | $126.3M | -$26.1M | |
| Levered Free Cash Flow | -$34.4M | $19.3M | $55.9M | $48.3M | $42.5M | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$11.4M | -$2.1M | -$9.3M | -$1.9M | -- | |
| Depreciation & Amoritzation | $13.9M | $14.4M | $14.6M | $15.3M | -- | |
| Stock-Based Compensation | $1.2M | $1.4M | $1.6M | $1.5M | -- | |
| Change in Accounts Receivable | $233K | $10M | $824K | $1.3M | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $10.4M | $21M | $10.1M | $12.9M | -- | |
| Capital Expenditures | $4.3M | $3.3M | $6.7M | $5.7M | -- | |
| Cash Acquisitions | $71.3M | $31M | -- | $43.7M | -- | |
| Cash From Investing | -$7.7M | -$2.6M | -$6.7M | $23M | -- | |
| Dividends Paid (Ex Special Dividend) | $2.3M | $2M | $5.5M | $5.6M | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $2.7M | -- | -- | $14M | -- | |
| Long-Term Debt Repaid | -$2.2M | -$2.3M | -$1.6M | -$43.3M | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -$612K | -$3.2M | -$518K | -$2K | -- | |
| Cash From Financing | -$2.4M | -$7.5M | -$7.7M | -$34.9M | -- | |
| Beginning Cash (CF) | $29.9M | $45.2M | $85.7M | $29.8M | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $303K | $11M | -$4.2M | $999K | -- | |
| Ending Cash (CF) | $30.2M | $56.1M | $81.5M | $30.8M | -- | |
| Levered Free Cash Flow | $6.1M | $17.7M | $3.4M | $7.2M | -- | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$10.8M | $554K | $9.7M | -$3.4M | $8.8M | |
| Depreciation & Amoritzation | $53.9M | $58.8M | $58M | $60.1M | $60.4M | |
| Stock-Based Compensation | $4.7M | $5.4M | $6M | $6.5M | $6.2M | |
| Change in Accounts Receivable | -$1M | -$12M | $10M | $833K | $326K | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $11.2M | $60.9M | $87.3M | $71M | $64.8M | |
| Capital Expenditures | $5.8M | $16.7M | $24.7M | $32.2M | $26.3M | |
| Cash Acquisitions | -- | $71.3M | $31M | -- | $43.7M | |
| Cash From Investing | -$40.3M | $24.9M | -$24M | -$58.8M | $55.4M | |
| Dividends Paid (Ex Special Dividend) | $282K | $8.4M | $18.6M | $22.3M | $24.5M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $118.4M | $47M | $172.9M | $246.3M | -- | |
| Long-Term Debt Repaid | -$241M | -$118.9M | -$157.8M | -$295.5M | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | $2M | |
| Other Financing Activities | -$5.4M | -$913K | -- | -$1.9M | -- | |
| Cash From Financing | $16.3M | -$81.1M | -$7.5M | -$73.3M | -$127.6M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$12.8M | $4.6M | $55.8M | -$61.1M | -$7.5M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | $5.4M | $44.2M | $62.6M | $38.8M | $38.5M | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$18.8M | $9.9M | $2.5M | $4M | $10.6M | |
| Depreciation & Amoritzation | $54.2M | $59.4M | $58.3M | $60.7M | $45.1M | |
| Stock-Based Compensation | $4.8M | $5.6M | $6.1M | $6.4M | $4.7M | |
| Change in Accounts Receivable | -$1.3M | -$2.2M | $803K | $1.3M | -$989K | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $28.8M | $71.5M | $76.4M | $73.8M | $51.8M | |
| Capital Expenditures | $9.5M | $15.7M | $28.1M | $31.3M | $20.5M | |
| Cash Acquisitions | $71.3M | $31M | -- | $43.7M | -- | |
| Cash From Investing | -$101.9M | $30M | -$28.1M | -$29.2M | $32.4M | |
| Dividends Paid (Ex Special Dividend) | $2.6M | $8.1M | $22.2M | $22.3M | $18.9M | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $111.7M | $44.3M | $172.9M | $260.3M | $15M | |
| Long-Term Debt Repaid | -$176.5M | -$119M | -$157.1M | -$337.2M | -$71M | |
| Repurchase of Common Stock | -- | -- | -- | -- | $2M | |
| Other Financing Activities | -$5.6M | -$3.5M | -$1.5M | -$1.3M | -- | |
| Cash From Financing | $71.6M | -$86.2M | -$7.7M | -$100.6M | -$92.7M | |
| Beginning Cash (CF) | $225.1M | $133.6M | $259.2M | $175.9M | $70.8M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$1.6M | $15.3M | $40.6M | -$55.9M | -$8.5M | |
| Ending Cash (CF) | $223.5M | $148.9M | $299.8M | $120M | $62.3M | |
| Levered Free Cash Flow | $19.3M | $55.9M | $48.3M | $42.5M | $31.3M | |
Get CLDT Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
CLDT
Sector
P/E ratio
622.52x
17.59x
PEG ratio
--
0.05x
P/B ratio
0.45x
0.83x
Price / LTM sales
1.13x
3.23x
Growth Metrics
CLDT
Sector
Revenue growth
-10.06%
3.09%
Earnings growth
-33.85%
4.98%
Revenue (5-year growth)
-0.69%
2.86%
Earnings forecast
--
$0.14
Profitability
CLDT
Sector
Profitability FY 2024
$79.3M
$153.7M
Return on invested capital
0.71%
2.03%
Return on assets
0.7%
1.81%
Return on equity
1.08%
3.5%
Earnings Date
Last Earnings Date
Nov
5
Next Earnings Date
Feb
26
Estimated Next Earnings Date
Feb
4
Balance Sheet
CLDT
Sector
Total cash
$21.4M
$73.7M
Short term investments
--
$11.9M
Total assets
$1.3B
$3.2B
Long term debt
$379.3M
$349.2M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Has Vistra Stock Gone Up?
Integrated power generation business Vistra (NYSE:VST) surprised investors recently when…
Why Is Amkor Stock Up So Much?
Semiconductor packaging and testing major Amkor (NASDAQ:AMKR) has started 2026…
Stock Ideas
Buy
56
Is NVDA Stock a Buy?
Market Cap: $4.5T
P/E Ratio: 63x
Buy
59
Is GOOG Stock a Buy?
Market Cap: $4T
P/E Ratio: 41x
Sell
48
Is GOOGL Stock a Buy?
Market Cap: $4T
P/E Ratio: 41x
Alerts
Buy
75
AGX alert for Jan 17
Argan, Inc. [AGX] is up 16.4% over the past day.
Buy
80
ASTS alert for Jan 17
AST Spacemobile, Inc. [ASTS] is up 14.32% over the past day.
Buy
84
IREN alert for Jan 17
IREN Ltd. [IREN] is up 11.35% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
